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Abstract
Purpose: Multifetal pregnancy reduction is a widespread
‘therapy’ to diminish the risk of prematurity and adverse
outcome for the survivors in higher order multiple gesta-
tion. The aim of our study was to determine the maternal
and neonatal outcome of multifetal pregnancies under a
conservative pregnancy management. Study Design: A
retrospective review of 112 multifetal pregnancies is pre-
sented. All higher order multiple pregnancies delivered
after 25 weeks of gestation and managed at a single insti-
tution between 1982 and 1999 are included. Results: Tri-
plets, quadruplets and quintuplets were delivered at a
mean gestational age of 31 + 5, 29 + 5 and 28 + 4 weeks,
respectively. The perinatal mortality was 14 for triplets
and 36 for quadruplets. No quintuplet died in the perina-
tal period. Respiratory distress syndrome occurred in
23% of triplets, 65% of quadruplets and 75% of quintu-
plets, intracranial hemorrhage was diagnosed in 14% of
triplets, 15% of quadruplets and 10% of quintuplets and
retinopathy of prematurity was found in 10% of triplets,
9% of quadruplets and 25% of quintuplets. Discussion:
Despite a low neonatal mortality, morbidity of higher
order multiple gestations remains significant. Mortality
and morbidity are related to preterm delivery but do not
exceed the rates of singletons or twins of an identical
gestational age. Favorable prognostic landmarks are a
gestational age 130 weeks and a number of fetuses per
pregnancy ^4. Conclusion: The risks of multifetal preg-
nancies are significant. Therefore, evidence-based coun-
seling of couples seeking treatment for infertility and pre-
vention of higher order multiple pregnancies through the
prudent use of reproductive techniques attains para-
mount importance.
Copyright © 2002 S. Karger AG, Basel
Introduction
The introduction of modern techniques of reproduc-
tive medicine has given rise to a major increase of multife-
tal pregnancies. The increased incidence of triplet, qua-
druplet and quintuplet pregnancies poses new and serious
medical and ethical problems to parents and obstetri-
cians. The widespread use of multifetal reduction tech-
niques [1–3] stresses the importance of accurate data
regarding maternal and fetal outcome of higher order
multiple pregnancies. Not only the mere chance of surviv-
al, but the chance of intact survival often determines pa-
rental choices.
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A search of the English literature demonstrates a pauci-
ty of data on the mortality and morbidity of multifetal
gestations derived from a single institution [4]. To our
knowledge, this is the largest series on outcome of multife-
tal pregnancies at a single tertiary care center. The objec-
tive of this study is to determine the fetal and maternal
outcome of multifetal pregnancies under a conservative
pregnancy management at a single tertiary care referral
center.
Methods
The Department of Obstetrics and Gynecology – Grosshadern,
Munich University Hospital, Germany, is a tertiary care perinatal
referral center serving metropolitan Munich and southern Bavaria.
The study comprised all multifetal pregnancies managed and deliv-
ered at our institution between 1982 and 1999.
For the purpose of this study, multifetal gestation was defined as
a pregnancy with three or more viable fetuses 125 weeks of gestation.
Gestational age was calculated by the date of the last known men-
struation or the date of conception for patients utilizing assisted
reproduction techniques and first trimester ultrasound in all other
cases.
Mothers were treated according to a standard protocol. None of
the mothers underwent multifetal pregnancy reduction therapy. Bed-
rest on an in- or outpatient basis was recommended in all cases after
reaching viability. Intravenous tocolysis with a ß-sympathomimetic
agent (Fenoterol) was initiated for preterm labor or cervical incom-
petence. A prophylactic tocolytic therapy was not used. Steroid thera-
py to enhance fetal lung maturity was given repetitively every 10 days
starting at 24 + 5 weeks (since 1984). This has recently (since 1999)
been limited to three doses due to concerns over steroid effects on the
developing fetus pending further investigations [5]. Antibiotics (first-
line antibiotics: penicillin, cephalosporin, clarithromycin; second-
line: imipenem, erythromycin) were prophylactically administrated
before 30 weeks. In case of intrauterine infection after 30 weeks,
treatment was continued until clinical and/or biochemical infection
parameters disappeared. All pregnancies were followed with serial
fetal ultrasonographic examinations every 4 weeks until viability.
After 25 weeks, time intervals of routine sonography were cut to 14
days. Discordant fetal growth was monitored with Doppler studies to
evaluate placental perfusion (since 1988) and repeated scans to deter-
mine interval growth at 10–14 days. Nonstress tests were initiated at
viability at weekly intervals for outpatients and daily for inpatients.
All neonates were resuscitated by two neonatologists. Surfactant
therapy has been available since 1991 and was administered at the
discretion of the neonatology staff depending on oxygen require-
ment, oxygen saturation and ventilation pressure.
The diagnosis of respiratory distress syndrome (RDS) was based
on dyspnea, PaO2 !50 mm Hg in the absence of oxygen supplemen-
tation and typical chest radiograph findings. Bronchopulmonary dys-
plasia (BPD) was defined as the need of oxygen supplementation
after 28 days of life. The diagnosis chronic lung disease (CLD) was
made when oxygen supplementation was required at the calculated
time of 36 weeks of gestation. Retinopathy of prematurity (ROP) was
graded according to its international classification [6]. The diagnosis
of necrotizing enterocolitis (NEC) was based on typical clinical and
radiographic findings [7]. All infants underwent ultrasonographic
examination of the head to detect intracranial hemorrhage (ICH).
Early neonatal mortality was defined as number of deaths of live-
born infants weighing 6500 g in the first 7 days of life per 1,000
liveborn infants. Late neonatal mortality was defined as the number
of deaths of liveborn infants after 7 days, but before 28 days of life
per 1,000 liveborn infants. Perinatal mortality was defined as the
sum of fetal deaths 124 weeks in addition to the early neonatal
deaths. Postneonatal deaths were defined as the number of deaths
after 28 days, but before 1 year of age per 1,000 livebirths.
Fetal mortality and morbidity were compared to historic series of
higher order multiple pregnancies and, on the other hand, to a cur-
rent control group of all singleton and twin pregnancies delivered at a
corresponding gestational age between 1988 and 1994 at our depart-
ment. Therefore, the study and control newborns were matched for
prematurity as the primary factor for perinatal morbidity and mor-
tality. The study period, comparable in higher order multiples and
controls, was chosen to represent equally both the era before and
after the availability of surfactant in neonatal intensive care (1991).
Medical charts of mother and infants were reviewed covering the
period until final discharge from hospital. For all quadruplet and
quintuplets, follow-up included neurological and developmental as-
sessment by a child development specialist at a corrected age of 3–5
months and subsequently after 1, 2 and 4 years. All children younger
than 24 months were subjected to the Griffith test to assess motor
and mental development. One set of quintuplets born in 1998 and
one set of quadruplets born in 1999 have not completed all follow-up
examinations due to their age (but as far as analyzed, develop nor-
mal).
Statistical analysis was performed using the ¯ test and Student’s
t test when appropriate. A p value ^0.05 was considered signifi-
cant.
Results
Among 26,693 deliveries between 1982 and 1999, 112
multifetal pregnancies occurred at the Department of
Obstetrics and Gynecology – Grosshadern, Munich Uni-
versity Hospital. These consisted of 94 sets of triplets, 14
sets of quadruplets and 4 sets of quintuplets. The inci-
dence of multifetal pregnancies was thus 1:284 for tri-
plets, 1:1,907 for quadruplets and 1:6,673 for quintu-
plets.
Prenatal Management
Of the 112 women, 16 patients conceived sponta-
neously (14.4%), 63 patients (56%) after in vitro fertiliza-
tion, gamete intrafallopian transfer or intracytoplasmatic
sperm injection, 21 (18.8%) after induction of ovulation,
6 (5.3%) following insemination and 5 (4.4%) conceived
with the aid of a combination of ovulation induction and
insemination.
Admission to the hospital for patients with triplet, qua-
druplet and quintuplet pregnancies occurred at a mean
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Table 1. Maternal complications in multifetal gestation
Triplet
pregnancies
(n = 94)
Quadruplet
pregnancies
(n = 14)
Quintuplet
pregnancies
(n = 4)
Total
(n = 112)
Preterm labor 40 (43%) 10 (71%) 3 (75%) 53 (47%)
Medical complications (cardiac, gastrointestinal,
respiratory, psychological decompensation) 41 (44%) 6 (43%) 1 (25%) 48 (43%)
P-PROM 18 (19%) 6 (43%) 2 (50%) 26 (23%)
Cervical incompetence 10 (11%) 2 (14%) 2 (50%) 15 (13%)
Maternal anemia 5 (5%) 2 (14%) 7 (6%)
Diabetes/gestational diabetes 1/4 (1/4%) 0/2 (0/14%) 1/6 (1/5%)
Preeclampsia/HELLP syndrome 3 (3%) 3 (21%) 6 (5%)
Chorioamnionitis 2 (2%) 2 (14%) 1 (25%) 5 (5%)
Urinary tract infection 4 (4%) 1 (7%) 5 (5%)
gestational age of 27 + 3, 25 + 0 and 24 + 4 weeks respec-
tively. The pregnancy prolongation achieved after hospi-
talization was 30 days for triplets, 38 days for quadruplets
and 24 days for quintuplets.
Twenty-five women underwent a prophylactic cerclage
between 12 and 21 weeks. Both Shirodkar’s and McDon-
ald’s technique were performed. Sixteen carried triplets
(17% of all triplet pregnancies, 16/94), 6 quadruplets
(43% of all quadruplet pregnancies, 6/14) and 3 quintu-
plets (75% of all quintuplet pregnancies, 3/4).
Premature labor or cervical incompetence occurred in
60/94 triplets (64%), 12/14 quadruplets (86%) and all
quintuplet pregnancies. Intravenous fenoterol was admin-
istrated in triplet pregnancies for a mean of 14.1 (0–51)
days, in quadruplet pregnancies for 27.6 (0–51) days and
quintuplet pregnancies for 5 (2–13) days. Preterm prema-
ture rupture of membranes (P-PROM) occurred in 26 of
112 pregnancies (23%), chorioamnionitis (uterine tender-
ness, serologic signs of infection, persistent labor despite
tocolysis, putrid vaginal discharge, maternal fever) in 5
(5%) and preeclampsia, defined according to the classifi-
cation of the International Society for the Study of Hyper-
tension in Pregnancy (ISSHP, 1986), in 6 of the 112 preg-
nancies (5%). Compared to other studies [8] –17–44% for
triplet mothers and 32–67% for quadruplets mothers –
the low incidence of preeclampsia in our data could be
related to earlier delivery (see table 6). Maternal compli-
cations are detailed in table 1.
Multifetal Growth
Compared to singleton and twin newborns, higher
order multiples tend to weigh less at birth. The percentage
of growth retardation, defined as birth weight ^ 10th per-
centile of singleton nomograms published by Hadlock et
al. [9], was 46% (129/281) for triplets, 50% (27/54) for
quadruplets and 55% (11/20) for quintuplets. Fetal sex
did not influence the birth weight significantly. Standard
biometry in triplets (biparietal diameter, abdominal cir-
cumference and femur length) proved to have a character-
istic growth pattern. Until 27 weeks, the 50th percentile of
triplets was higher (mean 2.2–10.4 mm) than in single-
tons. Multifetal growth flattened compared to singletons
between 27 and 31 weeks. It finally crossed and fell short
of the 50th percentile for singletons during the 31st week.
Fetuses from quadruplet and quintuplet pregnancies par-
alleled the course of triplets.
Labor and Delivery
All deliveries were by cesarean section except for one
triplet pregnancy that was delivered precipitously at 26
weeks immediately after arrival in the Labor and Delivery
Suite. Regarding the indication for delivery, a distinction
was made between maternal and fetal indications if possi-
ble. Maternal indications included cardiac, pulmonary,
gastrointestinal or general physical or psychological de-
compensation and preeclampsia (44%, 41/94 for triplets,
43%, 6/14 for quadruplets, and 25%, 1/4 for quintuplets),
preterm labor (38%, 36/94 for triplets, 50%, 7/14 for qua-
druplets, and 75%, 3/4 for quintuplets) as well as P-
PROM (19%, 18/94 for triplets, 43%, 6/14 for quadru-
plets, and 50%, 2/4 for quintuplets) and cervical incompe-
tence (11%, 10/94 for triplets, 21%, 3/14 for quadruplets,
and 50%, 2/4 for quintuplets).
Fetal indications were defined as growth retardation of
one or several fetuses (25%, 23/94 for triplets, 21%, 3/14
for quadruplets and 25%, 1/4 for quintuplets), fetal dis-
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Table 2. Survival and mortality of children from multifetal pregnancies
Triplets
(n = 282)
Quadruplets
(n = 55)
Quintuplets
(n = 20)
Total
(n = 357)
Stillbirths 125 + 0 SSW 1 (3.5‰) 1 (18.2‰) 2 (5.6‰)
Early neonatal mortality1 3 (10.6‰) 1 (18.2‰) 4 (11.2‰)
Late neonatal mortality2 4 (14.1‰) 1 (50‰) 5 (14.0‰)
Perinatal mortality3 4 (14.1‰) 2 (36.4‰) 6 (16.8‰)
Post neonatal mortality4 1 (3.5‰) 1 (18.2‰) 2 (100‰) 4 (11.2‰)
Survival to discharge from hospital 273/282 (968‰) 52/55 (945‰) 17/20 (850‰) 342/357 (958‰)
1 Early neonatal mortality: 0–7 days postnatal per 1,000 livebirths.
2 Late neonatal mortality: 8–28 days postnatal per 1,000 livebirths.
3 Perinatal mortality: stillbirths and early neonatal deaths per 1,000 livebirths.
4 Postneonatal (infant) mortality: 28 days–1 year per 1,000 livebirths.
tress (17%, 16/94 for triplets, 29%, 4/14 for quadruplets
and 0/4 for quintuplets), and chorioamnionitis (3%, 3/94
for triplets, 0/14 for quadruplets and 25%, 1/4 for quintu-
plets).
Neonatal Outcome
The 112 multifetal pregnancies resulted in 355 live-
births. For the higher order multiples studied, mean gesta-
tional age at birth for triplets was 31 + 5 weeks (25 + 0 to
36 + 3), for quadruplets 29 + 5 weeks (25 + 3 to 32 + 3),
and for the quintuplets 28 + 4 weeks (27 + 3 to 30 + 6).
The mean birth weight for triplets was 1,437 g (550–
2,420), for quadruplets 1,128 g (490–2,000) and for quin-
tuplets 1,030 g (670–1,870). The mean placental weight of
triplet, quadruplet and quintuplet pregnancies was 1,048,
1,174 and 1,260 g, respectively. This corresponded to 19,
21 and 20% of the mean total weight (fetal weights plus
placenta). There was no significant difference in gesta-
tional age at birth between patients that had received a
cerclage and those that did not, or between different
modes of conception. Of all newborns, 10% (32/355) had
an Apgar score after 5 min of live !7, and 14% were
(pre)acidemic (51/355) defined as an arterial pH !7.25.
Mortality
Of the 355 liveborn infants, 12 died (3.38%) before
being discharged from hospital. 97.2% (273/282) of tri-
plets, 94.5% (52/55) of quadruplets and 85% (17/20) of
quintuplets survived (table 2). No children with lethal
anomalies were among the studied higher order multiples.
Only 2 infants had congenital anomalies; 1 Cornelia de
Lange syndrome and 1 a complex heart defect (double
outlet right ventricle combined with ventricular septal
defect). Both fetuses had been growth retarded but neither
the heart defect nor the syndrome had been diagnosed
prenatally. There were 2 fetal deaths 125 weeks, 1 in a
triplet pregnancy and 1 in a quadruplet pregnancy. The
early neonatal mortality rate for triplets, quadruplets and
quintuplets was 10.6, 18.2 and 0 respectively. Thus, the
perinatal mortality was 14.1, 36.4 and 0. The late neona-
tal mortality rate for triplets and quintuplets was 14.1 and
50. Cause for the losses was RDS (n = 3), lung hypoplasia
(n = 2), ICH (n = 2), sepsis (n = 2), and acute heart failure,
shock and polyuric kidney failure (n = 1 each). There were
4 postneonatal deaths: 1 each amongst the triplets and
quadruplets, and 2 amongst the quintuplets. Causes for
postneonatal death were polyuric renal failure, sepsis,
respiratory failure and protracted shock.
The mortality rate for singleton and twin infants at our
institution for a comparable period of time (1988–1994)
was 39.1 (68/1,739). Even when adjusted for gestational
age at birth, there was no significant difference in mortali-
ty of infants from triplet and quadruplet pregnancies com-
pared to singleton/twin pregnancies from 26 weeks on.
Only very low gestational age (!27 weeks) or a high num-
ber of fetuses per pregnancy (14) increases the mortality
risk compared to controls (table 3).
After 30 weeks, there were no neonatal and fetal losses
while at lower gestational age (!30 weeks) 10% (9/92) of
triplets, 11% (3/27) of quadruplets and 20% (3/15) of
quintuplets died. Due to the limited number of pregnan-
cies with more than 3 fetuses, statistical significance is
only reached in triplets (p ! 0.01). The predictive value of
gestational age in terms of fetal and neonatal losses is also
present in the control pregnancies: mortality in singleton
and twin pregnancies delivered before 30 weeks was 8%,
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Table 3. Mortality of children from higher order multiple pregnancies (125 weeks) according to gestational age,
compared to controls (singletons/twins, 1988–1994)
Weeks Triplets Quadruplets Quintuplets Singletons/twins
26 4/9 (44%) p = 0.05* 2/3 (66%) p = 0.03* 12/71 (17%)
27 3/15 (20%) p = 0.89 p = 0.18 2/5 (40%) p = 0.08 10/142 (7%)
28 0/24 (0%)  1/4 (25%)  1/10 (10%) 
29 1/12 (8%) 0/8 (0%)
30 1/32 (3%) p = 0.13 0/12 (0%) p = 0.14 p = 0.56 20/315 (6%)
31 0/45 (0%)

0/12 (0%)

0/5 (0%)

32 0/45 (0%) p = 0.08 0/12 (0%) p = 0.55 26/1,211 (2%)
132 0/99 (0%)  0/4 (0%) 
Total 9/281 (3.20%) p = 0.57 3/55 (5.45%) p = 0.56 3/20 (15%) p = 0.01* 68/1,739 (3.91%)
* Significant difference.
Table 4. Neonatal complications in
multifetal gestation Triplets
(n = 281)
Quadruplets
(n = 54)
Quintuplets
(n = 20)
Total
(n = 355)
Respiratory distress syndrome 63 (23%) 35 (65%) 15 (75%) 115 (32%)
Bronchopulmonary dysplasia 2 (1%) 11 (20%) 3 (15%) 16 (5%)
Chronic lung disease 1 (0.4%) 2 (4%) 1 (5%) 4 (1%)
Intracranial hemorrhage I°–II° 25 (9%) 1 (5%) 26 (7%)
Intracranial hemorrhage III°–IV° 13 (5%) 8 (15%) 1 (5%) 22 (6%)
Retinopathy of prematurity I°–II° 23 (8%) 1 (5%) 24 (7%)
Retinopathy of prematurity III°–IV ° 5 (2%) 5 (9%) 4 (20%) 14 (4%)
Pneumothorax 8 (3%) 2 (4%) 3 (15%) 13 (4%)
Patent ductus arteriosus 15 (5%) 3 (6%) 2 (10%) 20 (6%)
Necrotizing enterocolitis 7 (2%) 2 (10%) 9 (3%)
Hydrocephalus 4 (1%) 2 (4%) 1 (5%) 7 (2%)
42/528 versus 2.2%, 26/1,211 in mothers delivering after
30 weeks (p ! 0.01).
Neonatal Complications
The mean duration of hospitalization amongst the tri-
plets was 30 days, 38 days for quadruplets and 24 days for
quintuplets. The incidence of neonatal complications
(RDS, ICH, ROP, NEC, pneumothorax, hydrocephalus)
is listed in table 4. Neonatal health impairment correlated
with low gestational age at birth and a high number of
fetuses per pregnancy (table 5). Before 30 weeks, 41% (34/
84) of triplets, 54% (13/24) of quadruplets and 75% (9/12)
of quintuplets showed some degree of health impairment.
After 30 weeks, only 25% (48/189) of triplets, 14% (4/28)
of quadruplets and none of the 5 quintuplets showed signs
of health impairment. These data define a statistical sig-
nificant difference for each category of multiples (triplets
p = 0.01, quadruplets p = 0.02 and quintuplets p = 0.05).
Health impairment in singleton and twin controls (before
30 weeks: 58%, 281/486 versus after 30 weeks: 8%, 89/
1,185) is reduced by growing gestational age in the same
way (p ! 0.01).
All quadruplets and quintuplets underwent develop-
mental assessment at defined intervals. Of these 69 chil-
dren, 53 (77%) are considered normal on developmental
assessment and do not have a neurological deficit. Four
children (6%) were diagnosed with a mild neurological
deficit (1 with muscular hypotonia, 1 (2%) with muscular
hypertonia, and 2 (3%) with hyperexcitability). Four chil-
dren (6%) were assessed with delayed mental and motor
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Table 5. Health impairment in surviving children from higher order multiple pregnancies (125 weeks) according to
gestational age, compared to controls (singletons/twins, 1988–1994).
Weeks Triplets Quadruplets Quintuplets Singletons/twins
26 3/5 (60%) p = 0.31 1/1 (100%) p = 0.61 47/59 (80%)
27 5/12 (42%) p = 0.00* p = 0.74 3/3 (100%) p = 1.00 99/132 (75%)
28 8/24 (33%)  2/3 (66%)  6/9 (67%) 
29 3/11 (27%) 7/8 (88%)
30 15/31 (48%) p = 0.36 3/12 (25%) p = 0.37 p = 0.04* 135/295 (46%)
31 17/45 (38%)

2/12 (17%)

0/5 (0%)

32 17/45 (38%) p = 0.00* 2/12 (17%) p = 0.45 89/1,185 (8%)
132 14/99 (14%)  0/4 (0%) 
Total 82/272 (30%) p = 0.00* 17/52 (33%) p = 0.07 9/17 (53%) p ! 0.01* 370/1,671 (22%)
* Significant difference.
development without specific neurological deficit, and 5
children (7%) were diagnosed with cerebral palsy (CP,
defined as athetoid impairment of movements as a result
of perinatal cerebral hypoxia). Three children (4%)
showed an isolated motor development deficiency; in 2 of
these a concurrent BPD was assumed to be the underlying
cause [28].
Overall, 70% (190/272) of the surviving triplets, 67%
(35/52) of quadruplets and 47% (8/17) of quintuplets were
discharged from hospital without handicap after 44 (12–
129), 84 (45–158) and 80 (43–198) days respectively.
Distribution of Mortality and Morbidity amongst
Families
Of all 94 families with triplets, 41 (44%) had at least 1
impaired child, and 7 (7%) had suffered a neonatal loss
(intrauterine fetal demise included). Amongst 14 parents
of quadruplets, 9 (64%) had an impaired child and 2
(14%) had suffered a neonatal loss. Two of the four fami-
lies (50%) with quintuplets had at least 1 impaired child,
and the same two families (50%) had suffered a neonatal
loss.
Discussion
More than 2 fetuses at a time multiply the probability
for an unfavorable pregnancy outcome. Different strate-
gies, multifetal pregnancy reduction techniques (fetocide)
versus conservative prenatal management, are used to
optimize the fetal and maternal outcome. The perinatal
mortality of multifetal gestation has decreased signifi-
cantly over the past decades (table 6). Both the number of
stillbirths and postnatal deaths contributed to the decline,
attesting to improved perinatal and neonatal care (ta-
ble 2).
Prenatal Management
Different management schemes to prolong the preg-
nancy such as prophylactic admission to the hospital for
bedrest, oral tocolysis, intravenous tocolytics or cervical
cerclage differ in their effectiveness [10].
Preterm labor is the most frequent complication in
multifetal pregnancies. A positive effect in the manage-
ment of premature labor and/or cervical incompetence
has been experienced with bedrest and intravenous toco-
lytics. A hospital setting allows thorough fetal and mater-
nal monitoring, but due to the lack of a control group its
effect on a prolongation of pregnancy after the onset of
preterm labor, cervical incompetence or P-PROM cannot
be evaluated. In twins, an increase of placental perfusion
through bedrest has been shown to reduce the number of
fetuses with intrauterine growth retardation after 30
weeks [11] and preterm delivery [12]. Nevertheless, re-
markable costs and physical as well as psychological ma-
ternal stress are to be considered [13]. Clinical observa-
tion suggests a prolongation of gestation by individually
adapted bedrest and intravenous tocolysis. In combina-
tion with betamethasone, adequate surveillance is needed
because of the increased risk of maternal pulmonary ede-
ma. However, the prophylactic administration of tocoly-
tics still lacks objective data [14–16].
The use of a prophylactic cerclage in multifetal preg-
nancy is still controversial [17]. A comparison of the mul-
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Table 6. Reports on perinatal outcome in triplet pregnancies [modi-
fied from 10])
Authors Study
period
Pregnancies Gestational
age, weeks
Perinatal
mortalitya, ‰
Kurtz 1931–1956 21 333
Itzkowic 1946–1976 59 33+4 232
Deale 1967–1976 367b 182
Daw 1958–1977 14 34+5 310
Holcberg 1960–1979 31 31+6 312
Loucopoulos 1965–1981 27 35+6 83c
Berg 1973–1981 8 40
Syrop 1946–1983 20 33+3 216
Weissman 1978–1987 29 33+3 138
Lipitz 1975–1988 78 33+1 93
Arlettaz 1985–1988 77d 33+0 89
Newman 1985–1988 198e 33+1 66
Levene 1989 143f 33 77
Seoud 1982–1990 15 31+6 0
Boulot 1985–1990 33 34+1 42g
Peaceman 1988–1991 15 34+5 0
Albrecht 1989–1994 57 33+0 41
Skrablin 1986–1997 52 32+6 167h
Strauss 1983–1999 94 31+5 14i
a Intrauterine and neonatal mortality 620 weeks.
b Pooled data from 150 hospitals.
c Intrauterine and neonatal mortality 628 weeks.
d Review of data from entire Switzerland.
e Pooled data from 24 centers.
f Review of data from England and Wales.
g Exclusion from 3 children died in the 21st week.
h Perinatal mortality 624 weeks.
i Perinatal mortality 125 weeks.
tifetal pregnancies studied shows no positive effect on the
length of gestation, birth weight or facilitation of pregnan-
cy management (bedrest, gestational age at hospitaliza-
tion, need for tocolysis) and hence we do not advocate its
use [18].
Gestational Age and Birth Weight
Premature birth becomes more likely with an increas-
ing number of fetuses, whereas birth weight of the new-
borns decreases. These rather intuitive findings support
the theory of a limited uterine capacity [19, 20]. However,
the mean total weight (fetuses and placenta) for triplet,
quadruplet and quintuplet pregnancies differed between
5,317 and 6,720 g, with quintuplet pregnancies reaching
the highest intrauterine weight. Thus, the same degree of
‘intrauterine crowding’ and therefore mechanical strain is
not regularly reached in pregnancies with 3 or 4 fetuses
and does not seem to be the limiting factor in every case.
Growth Curve
The growth curve of higher order gestation fetuses par-
allels the 25th percentile of singleton growth curves until
27 weeks [21]. Collins and Bleyl [22] have described that
beyond the 32nd week, multifetal growth slows down.
Our data confirmed and specified this growth pattern.
The use of growth nomograms from singleton pregnancies
overestimates intrauterine growth retardation in higher
order multiple gestation beginning from 27 weeks. As a
consequence, individual decisions on delivery due to pla-
cental insufficiency of 1 or more fetuses are at risk of
being made on the basis of maladapted growth curves.
Furthermore, discordant growth leads to difficult ob-
stetric compromises (intrauterine monitoring, timing of
intervention), saving 1 fetus from intrauterine fetal dam-
age and exposing its sibling to prematurity. Two of our
triplet pregnancies were delivered at 29 weeks because of
a severe growth retardation of 1 fetus. One infant was
found to have Cornelia de Lange syndrome and another
in an other triplet pregnancy a severe cardiac anomaly.
Both infants did not survive secondary to their anomaly
and did not profit from early delivery. Their siblings were
thus exposed to ‘unnecessary’ prematurity. Prolongation
of pregnancy and hence decreased risk of prematurity
need to be carefully weighed against the risk of intrauter-
ine placental insufficiency to one or more fetuses.
Mode of Delivery
From our point of view, an elective cesarean section is
the preferred mode of delivery for multifetal pregnancies,
as these are most likely premature. Not only does a cesar-
ean section avoid the risks associated especially with vagi-
nal operative deliveries, but ensures optimal logistic con-
ditions (e.g. two experienced neonatologists per child) to
give these infants the best possible start in life.
Neonatal Outcome
In our study, we were not able to demonstrate an
increased risk for triplets and quadruplets compared to
singleton or twin gestation. The perinatal mortality is
comparable to the figures from preterm singleton and
twin infants at the same gestational age except for very
immature triplets and quadruplets (26 weeks) and exces-
sive intrauterine crowding (14 fetuses) (table 3).
Mean gestational age for triplet pregnancies in prior
series is slightly higher (1 week) compared to our study.
Perinatal mortality in comparison dropped to a minimum
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of 14 (table 6). As suggested by Holcberg et al. [23], this
may be attributable to early diagnosis of a multifetal preg-
nancy. 85% of pregnancies studied resulted from sterility
treatment. Careful prenatal surveillance (ultrasound,
Doppler, cardiotocography, hospitalization) and intra-
uterine risks, which are more common in multifetal gesta-
tion, led to earlier delivery. Fetal distress and fetal deaths
have been reduced. Furthermore, advances in neonatolo-
gy (early surfactant administration) and care in a highly
skilled intensive care nursery (high-frequency ventilation)
may have contributed to the low neonatal mortality.
One could speculate that this reduction in mortality
(compared to table 6), especially of intrauterine fetal dem-
ise after fetuses reached viability (125 weeks), is accom-
panied by a concomitant increase in neonatal morbidity.
Regarding the parameters for early neonatal morbidity
(pH, Apgar score), no augmented risk relative to controls
of similar gestational ages could be found. However, the
rate of RDS and PDA in our study is identical or even
lower than previously reported, whereas the incidence of
severe ICH (III°–IV°) in our series is slightly higher [10,
24]. At our center, all premature infants, not only those
considered at risk for ICH, received a cranial sonography.
Thus, even asymptomatic children with mild ICH were
diagnosed. As an isolated finding, the incidence of ROP
III°–IV° (triplets 2%, quadruplets 9%, quintuplets 20%)
and as a sequel severe hyperopia (1+4 dioptry), myopia
(!–4 dioptry) or blindness was increased over singleton
gestation. This phenomenon has been observed in twin
gestations [22, 25] and has not yet been explained. Our
data confirm the results of the Cooperative Study of
Retrolental Fibroplasia [26] that a multiple pregnancy
defines an isolated risk for visual impairment.
Compared to other investigations [8, 27] in singletons
(1%) and multiples (1.3%) the rate of major congenital
anomalies in our study was low (0.6%). Despite the rather
large series of newborns analyzed, we interpret this dis-
crepancy to be derived from the limits in study size.
Our results show that accurate prenatal monitoring,
the use of adapted growth percentiles and advancing neo-
natal expertise have allowed a dramatic reduction of
intrauterine and postnatal mortality compared to former
series. Also, although the trend has moved towards deliv-
ery at earlier gestational age, this has not led to a rise in
morbidity. Thus, advances in perinatal medicine have
allowed us to achieve a decrease in mortality without the
cost of increased morbidity.
Children of multifetal pregnancies are challenged by
long-term physical health impairment. In twins, the risk
of CP is described to be 6.6–7.4‰ and therefore 4-fold
higher than in singletons (1.6–2.4‰). 15–32‰ of triplets
develop CP, this means a 3- to 5-fold increase compared
to twins. Quadruplets and quintuplets face a CP rate of
77–85‰ (3- to 5-fold of triplets). Before 32 weeks, CP
occurs in singletons, twins and quadruplet/quintuplets in
9, 12 and 8.5% respectively [28, 29]. Developmental
assessment of all analyzed quadruplets and quintuplets in
our series (CP 73‰) confirmed the data from the litera-
ture.
As expected, quintuplets had the least favorable prog-
nosis regarding morbidity and mortality. Only 8 of 17
quintuplet neonates (47%) survived without even a mild
handicap, whereas quadruplets –35 out of 52 (67%) – and
triplets –190 out of 272 (70%) – survived without health
impairment. Table 5 details the chances of intact survival
in relation to gestational age. Gestational age shows a
close correlation to morbidity and mortality. Triplets
born before 30 weeks had a 1.85 times relative risk for
morbidity and mortality compared to those born after 30
weeks. Among quadruplets born after 30 weeks, the factor
of risk reduction is 4.15. All impaired quintuplets were
born before 29 weeks. However, the incidence of a
deceased or impaired child relative to families shows that
only 50% (47/94) of couples with triplets and 36% (5/14)
with quadruplet and 25% (1/4) quintuplet pregnancies
respectively were unaffected.
In conclusion, the risk of multifetal pregnancies re-
mains significant. Maternal morbidity is chiefly related to
preterm labor. Fetal morbidity and mortality is mainly
related to prematurity but is not significantly increased in
singletons and twins of similar gestational age after 26
weeks. Intensive prenatal monitoring may detect early
signs of fetal compromise. Timely delivery and excellent
neonatal care may significantly lower perinatal mortality.
In terms of risk assessment, gestational age over 30 weeks
and a maximum of 4 fetuses per pregnancy define prog-
nostic landmarks. However, even optimal use of resources
leaves more than every second family to cope with a dead
or impaired child.
Multifetal pregnancy reduction (feticide) is ethically
problematic and difficult to accept for some patients and
therefore should not be part of routine (infertility) treat-
ment planning. The presented data establish the basis for
a counterbalance in counseling couples seeking treatment
for infertility and advocate the prudent use of modern
reproductive techniques to prevent multifetal pregnan-
cies.
Multifetal Gestation –
Outcome of 112 Pregnancies
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